S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
S&P 500   4,050.83 (+0.57%)
DOW   32,859.03 (+0.43%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
NASDAQ:LIVN

LivaNova - LIVN Stock Forecast, Price & News

$42.71
+0.41 (+0.97%)
(As of 03/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$42.28
$42.91
50-Day Range
$40.84
$58.14
52-Week Range
$40.26
$88.00
Volume
350,438 shs
Average Volume
543,881 shs
Market Capitalization
$2.29 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$76.20

LivaNova MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
78.4% Upside
$76.20 Price Target
Short Interest
Healthy
3.62% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.66mentions of LivaNova in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
17.83%
From $2.58 to $3.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

124th out of 1,009 stocks

Electromedical Equipment Industry

2nd out of 23 stocks


LIVN stock logo

About LivaNova (NASDAQ:LIVN) Stock

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiopulmonary and Other segments. The Cardiopulmonary segment is involved in the development, production and sale of cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, and related accessories. The Other segment includes heart valves business and corporate shared service expenses for finance, legal, human resources, information technology, and corporate business development. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
LivaNova Reports Third-Quarter 2022 Results
Breakeven Is Near for LivaNova PLC (NASDAQ:LIVN)
LivaNova Enters Oversold Territory (LIVN)
See More Headlines
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Company Calendar

Last Earnings
2/22/2023
Today
3/30/2023
Next Earnings (Confirmed)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LIVN
Employees
2,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$76.20
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$62.00
Forecasted Upside/Downside
+79.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-86,250,000.00
Pretax Margin
-7.35%

Debt

Sales & Book Value

Annual Sales
$1.02 billion
Cash Flow
$6.29 per share
Book Value
$22.56 per share

Miscellaneous

Free Float
53,361,000
Market Cap
$2.27 billion
Optionable
Optionable
Beta
0.87

Key Executives

  • Damien McDonaldDamien McDonald
    Chief Executive Officer & Executive Director
  • Alex Shvartsburg
    Chief Financial Officer
  • Bryan D. Olin
    Senior Vice President & Head-Product Development
  • Michael David Hutchinson
    Secretary, Chief Legal Officer & Senior VP
  • Marco DolciMarco Dolci
    President-Cardiopulmonary













LIVN Stock - Frequently Asked Questions

Should I buy or sell LivaNova stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LIVN shares.
View LIVN analyst ratings
or view top-rated stocks.

What is LivaNova's stock price forecast for 2023?

4 brokerages have issued 12-month price targets for LivaNova's stock. Their LIVN share price forecasts range from $62.00 to $95.00. On average, they expect the company's stock price to reach $76.20 in the next twelve months. This suggests a possible upside of 78.4% from the stock's current price.
View analysts price targets for LIVN
or view top-rated stocks among Wall Street analysts.

How have LIVN shares performed in 2023?

LivaNova's stock was trading at $55.54 at the beginning of the year. Since then, LIVN stock has decreased by 23.1% and is now trading at $42.71.
View the best growth stocks for 2023 here
.

Are investors shorting LivaNova?

LivaNova saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 1,940,000 shares, a decline of 13.0% from the February 28th total of 2,230,000 shares. Based on an average trading volume of 523,900 shares, the short-interest ratio is presently 3.7 days.
View LivaNova's Short Interest
.

When is LivaNova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our LIVN earnings forecast
.

How can I listen to LivaNova's earnings call?

LivaNova will be holding an earnings conference call on Wednesday, May 3rd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were LivaNova's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) released its quarterly earnings results on Wednesday, February, 22nd. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.09. The business earned $274.90 million during the quarter, compared to analyst estimates of $262.16 million. LivaNova had a negative net margin of 8.44% and a positive trailing twelve-month return on equity of 10.49%. The firm's revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter last year, the company earned $0.57 earnings per share.

What guidance has LivaNova issued on next quarter's earnings?

LivaNova updated its FY23 earnings guidance on Wednesday, February, 22nd. The company provided EPS guidance of $2.45-2.65 for the period, compared to the consensus EPS estimate of $2.48.

What is Damien McDonald's approval rating as LivaNova's CEO?

47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees.

What other stocks do shareholders of LivaNova own?
What is LivaNova's stock symbol?

LivaNova trades on the NASDAQ under the ticker symbol "LIVN."

Who are LivaNova's major shareholders?

LivaNova's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Barrow Hanley Mewhinney & Strauss LLC (4.33%), Harris Associates L P (3.75%), Eminence Capital LP (3.25%), Morgan Stanley (3.08%), Dimensional Fund Advisors LP (2.04%) and Victory Capital Management Inc. (2.00%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci.
View institutional ownership trends
.

How do I buy shares of LivaNova?

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LivaNova's stock price today?

One share of LIVN stock can currently be purchased for approximately $42.71.

How much money does LivaNova make?

LivaNova (NASDAQ:LIVN) has a market capitalization of $2.29 billion and generates $1.02 billion in revenue each year. The company earns $-86,250,000.00 in net income (profit) each year or ($1.62) on an earnings per share basis.

How many employees does LivaNova have?

The company employs 2,900 workers across the globe.

How can I contact LivaNova?

LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The official website for the company is www.livanova.com. The company can be reached via phone at 442033250660, via email at investor.relations@livanova.com, or via fax at 281-218-9332.

This page (NASDAQ:LIVN) was last updated on 3/30/2023 by MarketBeat.com Staff